- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Phospho-Alpha Synuclein Tyr125 Antibody 32S65 / SNCA Phospho Tyr125 Monoclonal Antibody recognizes alpha-synuclein phosphorylated at tyrosine 125, a post-translational modification implicated in the regulation of synuclein structure, protein interactions, and neuronal signaling. Alpha-synuclein is encoded by the SNCA gene and functions primarily as a presynaptic protein involved in synaptic vesicle organization and neurotransmitter release. Its intrinsically disordered structure allows it to adopt different conformations in response to membrane binding and interactions with other cellular components. Phosphorylation provides an additional mechanism through which these properties may be regulated.
Alpha-synuclein contains an N-terminal membrane-binding region, a central hydrophobic domain associated with aggregation, and an acidic C-terminal region involved in protein interactions. Tyr125 is located within the C-terminal region, where phosphorylation can influence local charge distribution and intermolecular interactions. Several tyrosine kinases have been implicated in alpha-synuclein phosphorylation, including members of the Src and Abl kinase families. The biological consequences of individual phosphorylation events depend on the modified residue, cellular environment, and interactions with other regulatory mechanisms.
Phosphorylation at Tyr125 has been investigated in relation to alpha-synuclein aggregation, protein clearance, and cellular stress responses. Experimental studies suggest that C-terminal tyrosine phosphorylation can influence the formation or stability of aggregated species, although its effects are context-dependent. Tyr125 phosphorylation should therefore not be interpreted as an exclusive marker of pathological alpha-synuclein. It is distinct from phosphorylation at Ser129, which is strongly enriched in Lewy body pathology and is more extensively studied as a marker of pathological inclusions.
Alpha-synuclein aggregation is associated with Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. These synucleinopathies involve abnormal protein accumulation, impaired cellular homeostasis, and progressive dysfunction of vulnerable neuronal or glial populations. Alterations in phosphorylation may affect alpha-synuclein interactions with membranes, degradation machinery, and other proteins involved in maintaining proteostasis. Understanding site-specific phosphorylation is important for distinguishing regulatory modifications from changes associated with protein misfolding. The Phospho-Alpha Synuclein Tyr125 Antibody 32S65 provides a clone-defined reagent for investigating this modification in the context of synuclein regulation, kinase signaling, and neurodegenerative disease mechanisms.
NSJ Bioreagents offers Phospho-Alpha Synuclein (pTyr125) antibody as a reliable reagent for studies of protein aggregation, phosphorylation, and neurodegeneration. With proven specificity across multiple assay formats, it supports ongoing research into the mechanisms and therapeutic targeting of synucleinopathies.
Optimal dilution of the Phospho-Alpha Synuclein Tyr125 Antibody 32S65 / SNCA Phospho Tyr125 Monoclonal Antibody should be determined by the researcher.
A synthesized peptide derived from human Phospho-alpha Synuclein (Y125) was used as the immunogen for the Phospho-Alpha Synuclein Tyr125 Antibody 32S65.
Store the Phospho-Alpha Synuclein Tyr125 Antibody 32S65 at -20oC.
Phospho-alpha-synuclein Y125 antibody, Alpha-synuclein phospho-Tyr125 antibody, Phosphorylated alpha-synuclein antibody, Phospho-SNCA Tyr125 antibody, Alpha-synuclein pY125 antibody, Phospho-synuclein alpha antibody, Tyrosine 125 phosphorylated SNCA antibody, Alpha-synuclein phosphotyrosine 125 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.